Latest filing published 20 May 2024 for Replimune Group, Inc., €105k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Colin Love: trading record in brief
Colin Love discloses dealings in Replimune Group, Inc. to SEC (Form 4). The record holds 46 filings, for trades running from 23 September 2019 to 16 May 2024.
Every open-market trade on record is a sale: 43 sales worth €11.2M. Besides market trades, the filings include 3 share grants. Since January 2024: no purchases and 1 sale on the market.
The record was last updated on 20 May 2024 with an open-market sale (€105k) in Replimune Group, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Colin Love
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 17,615 shares@ US$6.471.7% of flowCommon StockSEC:0001104659-24-063562:0
- 10,775 shares@ US$18.052.9% of flowCommon StockSEC:0001104659-23-062375:0
- 40,000 shares0Common StockSEC:0001104659-23-041723:0
- 6,324 shares@ US$14.592.7% of flowCommon StockSEC:0001104659-22-062611:0
- 26,250 shares0Common StockSEC:0001104659-22-042760:0
- 2,200 shares@ US$31.161.8% of flowCommon StockSEC:0001104659-21-127727:0
- 30,000 shares@ US$31.2324.6% of flowCommon StockSEC:0001104659-21-117070:0
- 27,300 shares@ US$30.0021.5% of flowCommon StockSEC:0001104659-21-107453:0
- 30,000 shares@ US$32.0225.2% of flowCommon StockSEC:0001104659-21-093195:0
- 17,800 shares@ US$33.8015.4% of flowCommon StockSEC:0001104659-21-082229:0
10 of 10 declarations
